These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4593892)
41. Topical product design and extemporaneous compounding in dermatology. Krochmal L; Patel B Adv Dermatol; 1992; 7():231-52; discussion 253. PubMed ID: 1739582 [No Abstract] [Full Text] [Related]
42. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets]. Arias I; Cadorniga R Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139 [No Abstract] [Full Text] [Related]
43. [Measurement of the biologic-availability of an active principle applied topically]. Gumma A Pharm Acta Helv; 1971 Dec; 46(12):730-6. PubMed ID: 5143004 [No Abstract] [Full Text] [Related]
44. Proceedings: In vitro:in vivo correlation and ageing studies of commercial hydrochlorothiazide tablets. Hossie RD; Mattok GL; McGilveray IJ Rev Can Biol; 1973; 32():85-9. PubMed ID: 4777590 [No Abstract] [Full Text] [Related]
51. Pharmaceutical sciences--1975: literature review of pharmaceutics II. Goodhart FW; Eichman ML J Pharm Sci; 1976 Aug; 65(8):1101-39. PubMed ID: 789855 [No Abstract] [Full Text] [Related]
52. Drug permeation through membranes. II. Simultaneous dissolution and permeation of drug from solid dosage forms. Lovering EG; McRae KB J Pharm Sci; 1973 Jun; 62(6):971-4. PubMed ID: 4712634 [No Abstract] [Full Text] [Related]
53. Interfacial barriers to the transport of sterols and other organic compounds at the aqueous polysorbate 80-hexadecane interface. Bikhazi AB; Higuchi WI Biochim Biophys Acta; 1971 Jun; 233(3):676-87. PubMed ID: 4329757 [No Abstract] [Full Text] [Related]
54. Preformulation studies. II. Stability of drug substances in solid pharmaceutical systems. Tingstad J; Dudzinski J J Pharm Sci; 1973 Nov; 62(11):1856-60. PubMed ID: 4758086 [No Abstract] [Full Text] [Related]
55. The general problem of drug bioavailability and its assessment in man. Smith RN Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894 [No Abstract] [Full Text] [Related]
56. Mass transport phenomena and models: theoretical concepts. Flynn GL; Yalkowsky SH; Roseman TJ J Pharm Sci; 1974 Apr; 63(4):479-510. PubMed ID: 4828694 [No Abstract] [Full Text] [Related]
58. [Determination of the rate of swelling of compressed dosage forms using hydrophilic gel-forming agents]. Süss W Pharmazie; 1986 Nov; 41(11):816. PubMed ID: 3562518 [No Abstract] [Full Text] [Related]
59. Release study of sulfaethylthiadiazole (SETD) from a tablet dosage form prepared from spray-congealed formulations of SETD and wax. Hamid IS; Becker CH J Pharm Sci; 1970 Apr; 59(4):511-4. PubMed ID: 4909462 [No Abstract] [Full Text] [Related]
60. Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects. Heimlich KR J Pharm Sci; 1972 Oct; 61(10):1686-9. PubMed ID: 5072432 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]